These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 3142676

  • 1. Different immune functions of peripheral blood, regional lymph node, and tumor infiltrating lymphocytes in lung cancer patients.
    Nakamura H, Ishiguro K, Mori T.
    Cancer; 1988 Dec 15; 62(12):2489-97. PubMed ID: 3142676
    [Abstract] [Full Text] [Related]

  • 2. Functional character and augmentation of lymphocytes in regional lymph nodes of patients with lung cancer.
    Watanabe Y, Hashizume Y, Shimizu J, Yoshida M, Watanabe S, Iwa T, Sakai S, Migita S, Sato H, Murayama T.
    Am Rev Respir Dis; 1990 Oct 15; 142(4):769-74. PubMed ID: 2221581
    [Abstract] [Full Text] [Related]

  • 3. Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer.
    Ohta T, Kikuchi H, Ogata H, Iwata K, Yoshida K, Katayama K, Watanabe H.
    Cancer; 1992 Aug 15; 70(4):741-8. PubMed ID: 1386555
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes.
    Anderson TM, Ibayashi Y, Tokuda Y, Colquhoun SD, Holmes EC, Golub SH.
    Cancer Res; 1988 Mar 01; 48(5):1180-3. PubMed ID: 3257716
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity of regional lymph node lymphocytes in patients with lung cancer.
    Yaita H, Yasumoto K, Nagashima A, Sugimachi K, Nomoto K.
    J Surg Oncol; 1988 Jul 01; 38(3):165-72. PubMed ID: 3260643
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun 01; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 18. Assessment of tumour-infiltrating lymphocytes, regional lymph node lymphocytes and peripheral blood lymphocytes and their reaction to interferon-gamma in patients with renal carcinoma.
    Onishi T, Machida T, Masuda F, Hatano T, Shirakawa H, Natori T, Hamamoto M, Matsuoka Y.
    Br J Urol; 1991 May 01; 67(5):459-66. PubMed ID: 1903998
    [Abstract] [Full Text] [Related]

  • 19. Natural killer and lymphokine-activated killer cell-mediated cytotoxicity in patients with oral cancer.
    Gangal SG, Tatake RJ, Krishnan N, Mukhopadhyaya R, Naik SL, Fakih AR, Rao RS.
    Semin Surg Oncol; 1989 May 01; 5(5):347-50. PubMed ID: 2814145
    [Abstract] [Full Text] [Related]

  • 20. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.
    Mukhopadhyaya R, Tatake RJ, Krishnan N, Rao RS, Fakih AR, Naik SL, Gangal SG.
    J Clin Lab Immunol; 1989 Sep 01; 30(1):21-5. PubMed ID: 2641790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.